✦ LIBER ✦

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

✍ Scribed by P.M Ridker; N Rifai; M Clearfield

Book ID: 114346756
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 47 KB
Volume: 10
Category: Article
ISSN: 1062-1458
DOI: 10.1016/s1062-1458(01)00460-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Justification for the Use of Statins in

Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)—Can C-Reactive Protein Be Used to Target Statin Therapy in Primary Prevention?

✍ Samia Mora; Paul M. Ridker 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 374 KB

Potential cost-effectiveness of C-reacti

Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia

✍ Gavin J Blake; Paul M Ridker; Karen M Kuntz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 292 KB

STATIN THERAPY IS COST-EFFECTIVE FOR VAS

STATIN THERAPY IS COST-EFFECTIVE FOR VASCULAR EVENT PREVENTION IN ADULTS WITH ELEVATED C-REACTIVE PROTEIN: IMPLICATIONS OF JUPITER

✍ Slejko, Julia F.; Page, Robert L.; Sullivan, Patrick W. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Influence and Critique of the JUPITER Tr

Influence and Critique of the JUPITER Trial (Statins v No Statins for Primary Prevention of Cardiovascular Events in Patients with Normal Lipids and Elevated C-Reactive Protein)

✍ Russell H. Samson; Deepak G. Nair 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Cost-Effectiveness Analysis for Statin T

Cost-Effectiveness Analysis for Statin Therapies in the Primary Prevention of Coronary Heart Disease in Italy

✍ Dr Patrizia Berto, Vicky Munro, Antonio Gaddi, Cristina Negrini, John Hutton, Ol 📂 Article 📅 2000 🏛 Springer International Publishing AG 🌐 English ⚖ 236 KB

Primary prevention of vascular events in

Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study

✍ Fonseca, Francisco AH; Izar, Maria Cristina O 📂 Article 📅 2009 🏛 Expert Reviews 🌐 English ⚖ 630 KB